2016 - Member of Academia Europaea
Fellow of The Academy of Medical Sciences, United Kingdom
Munir Pirmohamed mainly focuses on Pharmacology, Immunology, Pharmacogenetics, Drug and Metabolite. His studies in Pharmacology integrate themes in fields like P-glycoprotein, Toxicity and In vivo. His Immunology study deals with Genotype intersecting with Bioinformatics.
He has included themes like Guideline, Internal medicine, Warfarin and Intensive care medicine in his Pharmacogenetics study. The study incorporates disciplines such as Gastroenterology and Phenytoin in addition to Internal medicine. The Drug study combines topics in areas such as Idiosyncrasy and Hapten.
His main research concerns Pharmacology, Internal medicine, Immunology, Pharmacogenetics and Drug. His work carried out in the field of Pharmacology brings together such families of science as Metabolite, Carbamazepine, Toxicity and In vivo. Munir Pirmohamed interconnects Gastroenterology and Endocrinology in the investigation of issues within Internal medicine.
Munir Pirmohamed has included themes like Genome-wide association study and Allele in his Immunology study. His research in Pharmacogenetics intersects with topics in Abacavir, Bioinformatics, Warfarin and Intensive care medicine. His work deals with themes such as Pharmacogenomics, Disease, Dosing and Drug reaction, which intersect with Intensive care medicine.
His primary areas of study are Internal medicine, Pharmacogenomics, Intensive care medicine, Immunology and Pharmacology. The Internal medicine study combines topics in areas such as Gastroenterology, Genome-wide association study and Oncology. In his study, Randomized controlled trial is strongly linked to Clinical trial, which falls under the umbrella field of Pharmacogenomics.
His Intensive care medicine research includes themes of Disease, MEDLINE, Warfarin and Nephrotoxicity. Pharmacology connects with themes related to Pharmacogenetics in his study. His biological study spans a wide range of topics, including Carbamazepine, Dosing and Abacavir.
Munir Pirmohamed mainly investigates Internal medicine, Pharmacogenomics, Pharmacology, Pharmacogenetics and Intensive care medicine. The study incorporates disciplines such as Physical therapy and Single-nucleotide polymorphism in addition to Internal medicine. He combines subjects such as Precision medicine, Clinical trial, Personalized medicine and Disease with his study of Pharmacogenomics.
His Pharmacology research is mostly focused on the topic Drug reaction. His work carried out in the field of Pharmacogenetics brings together such families of science as Guideline, Gout, Asthma and Allopurinol. His Intensive care medicine study combines topics from a wide range of disciplines, such as Nephrology, Warfarin, Nephrotoxicity, Young adult and Drug.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Munir Pirmohamed;Sally James;Shaun Meakin;Chris Green.
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom;Francesco Iorio;Patrick A Eyers;K Jane Escott.
Nature Reviews Drug Discovery (2019)
Phase I Clinical Trial of Oral Curcumin: Biomarkers of Systemic Activity and Compliance
Ricky A. Sharma;Stephanie A. Euden;Sharon L. Platton;Darren N. Cooke.
Clinical Cancer Research (2004)
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
Ann K Daly;Peter T Donaldson;Pallav Bhatnagar;Yufeng Shen.
Nature Genetics (2009)
Pharmacodynamic and Pharmacokinetic Study of Oral Curcuma Extract in Patients with Colorectal Cancer
Ricky A. Sharma;Heather R. McLelland;Kirsti A. Hill;Christopher R. Ireson.
Clinical Cancer Research (2001)
HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans
Mark McCormack;Ana Alfirevic;Stephane Bourgeois;John J. Farrell.
The New England Journal of Medicine (2011)
A Randomized Trial of Genotype-Guided Dosing of Warfarin
Munir Pirmohamed;Girvan Burnside;Niclas Eriksson;Andrea L. Jorgensen.
The New England Journal of Medicine (2013)
Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes
Emma C. Davies;Christopher F. Green;Stephen Taylor;Paula R. Williamson.
PLOS ONE (2009)
Active Transport of Imatinib into and Out of Cells: Implications for Drug Resistance
Julia Thomas;Lihui Wang;Richard E. Clark;Munir Pirmohamed.
Emergence and global spread of epidemic healthcare-associated Clostridium difficile.
Miao He;Fabio Miyajima;Paul Roberts;Louise Ellison.
Nature Genetics (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: